Aptinyx Inc. Common Stock
APTX
APTX was delisted on the 18th of May, 2023.
50 hedge funds and large institutions have $479M invested in Aptinyx Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 50 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ASP
Adams Street Partners
Chicago,
Illinois
|
+$86.3M |
| 2 |
NLVP
New Leaf Venture Partners
New York
|
+$70.4M |
| 3 |
FM
Frazier Management
Seattle,
Washington
|
+$68.3M |
| 4 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$47.6M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$29.5M |
Top Sellers
APTX Hedge Fund Activity: Q2 2018 in Review
50 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Aptinyx Inc. Common Stock (APTX) for Q2 2018, worth a combined $479M.
Buyers outnumbered sellers: 50 funds opened new APTX positions and 0 closed out — a net gain of 50 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Adams Street Partners, opening a new position worth an estimated $86.3M.
- 50 institutional investors held Aptinyx Inc. Common Stock (APTX) as of Q2 2018, up from 0 in Q1 2018.
- Funds reported $479M of Aptinyx Inc. Common Stock stock for Q2 2018.
- 50 funds opened new Aptinyx Inc. Common Stock positions in Q2 2018 and 0 closed out, a net change of +50 holders.
- The largest Aptinyx Inc. Common Stock buyer in Q2 2018 was Adams Street Partners, an estimated $86.3M added.
Based on aggregated 13F filings for Q2 2018.